Skip to main content

Cardiovascular

Featured Article
“Homeless patients with hypertension and/or type 2 diabetes who had at least one visit with a pharmacist showed some improved health outcomes,” researchers wrote.
Patients with venous thromboembolism (VTE) who take statins may have a significantly lower risk of recurrent VTE, according to a new study.

Insights

Mark Munger, PharmD, discusses why the search for improving outcomes in HFrEF using newer anti-coagulants continues.
Mark Munger, PharmD, discusses recent study findings, which show that ranolazine increases the adverse effect profile of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, raising concern for patient safety.
Kiersten Combs, vice president of US Cardiovascular & Metabolic Disease, and Jim McDermott, vice president of US Medical Affairs and Metabolism, both at AstraZeneca, highlight how the use of Farxiga and other SGLT2 inhibitors impact payers and…
Mark Munger, PharmD, explains why there is a critical need to develop a treatment to reduce the incidence of NSAID-induced cardiovascular adverse events, especially heart failure.

Interactive Features

Most patients who received guideline-recommended medication had doses lower than those recommended, the researchers note.
What percentage of Medicare beneficiaries do not take their blood pressure medications as directed, according to the CDC?
A minimum of ___________ should elapse before patients who take patiromer for treatment of hyperkalemia ingest other oral medications.
Back to Top